+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurological Disorder Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 -2027

  • ID: 5011450
  • Report
  • March 2020
  • Region: Global
  • 251 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amgen, Inc
  • AstraZeneca plc
  • Bayer AG
  • Biogen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • MORE
Neurological Disorder Drugs Market - Scope of the Report

The publisher’s report on the global neurological disorder drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global neurological disorder drugs market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurological disorder drugs market from 2019 to 2027.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global neurological disorder drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global neurological disorder drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global neurological disorder drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurological disorder drugs market.

The report also delves into the competitive landscape of the global neurological disorder drugs market. Key players operating in the global neurological disorder drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurological disorder drugs market that have been profiled in this report.

Key Questions Answered in Neurological Disorder Drugs Market Report
  • What is the sales/revenue generated by neurological disorder drugs across all regions during the forecast period?
  • What are the opportunities in the global neurological disorder drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which disorder segment is expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Neurological Disorder Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global neurological disorder drugs market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurological disorder drugs market in terms of disorder, drug class, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global neurological disorder drugs market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen, Inc
  • AstraZeneca plc
  • Bayer AG
  • Biogen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neurological Disorder Drugs Market

4. Market Overview
4.1. Introduction & Overview
4.2. Product Overview
4.3. Market Dynamics
4.4. Global Neurological Disorder Drugs Market Analysis and Forecast, 2017–2027

5. Market Outlook
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Regulatory Scenario

6. Global Neurological Disorder Drugs Market Analysis and Forecast, by Disorder
6.1. Introduction & Definition
6.2. Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017–2027
6.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder

7. Global Neurological Disorder Drugs Market Analysis and Forecast, by Drug Class
7.1. Introduction & Definition
7.2. Global Neurological Disorder Drugs Market Value (US$) Forecast, by Drug Class, 2017–2027
7.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class

8. Global Neurological Disorder Drugs Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
8.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel

9. Global Neurological Disorder Drugs Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Region
9.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Region

10. North America Neurological Disorder Drugs Market Analysis and Forecast
10.1. Introduction
10.2. North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017–2027
10.3. North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
10.4. North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
10.5. North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.6. North America Neurological Disorder Drugs Market Attractiveness Analysis

11. Europe Neurological Disorder Drugs Market Analysis and Forecast
11.1. Introduction
11.2. Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017–2027
11.3. Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
11.4. Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
11.5. Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.6. Europe Neurological Disorder Drugs Market Attractiveness Analysis

12. Asia Pacific Neurological Disorder Drugs Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017–2027
12.3. Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
12.4. Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
12.5. Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.6. Asia Pacific Neurological Disorder Drugs Market Attractiveness Analysis

13. Latin America Neurological Disorder Drugs Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017–2027
13.3. Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
13.4. Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
13.5. Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.6. Latin America Neurological Disorder Drugs Market Attractiveness Analysis

14. Middle East & Africa Neurological Disorder Drugs Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017–2027
14.3. Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
14.4. Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
14.5. Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.6. Middle East & Africa Neurological Disorder Drugs Market Attractiveness Analysis

15. Competition Landscape
15.1. Competition Matrix
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
Note: Product cover images may vary from those shown
3 of 3
  • Novartis AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • Pfizer, Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Amgen, Inc
  • UCB S.A.
  • Eli Lilly and Company
  • Biogen
Note: Product cover images may vary from those shown
Adroll
adroll